NEW YORK (GenomeWeb News) – Nabsys today said that it has raised $20 million in a Series D financing round, which will support the launch of the firm's semiconductor-based single-molecule sequencing platform.

The financing round was led by Bay City Capital, a new investor in the firm, with previous investors Point Judith Capital and Stata Venture Partners also participating.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.